Entity
  • Vivet Therapeutics

    Created in 2016
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    240 5,171
  • Activities

  • Technologies

  • Entity types

  • Location

    80 Bd Haussmann, 75008 Paris, France

    Paris

    France

  • Employees

    Scale: 11-50

    Estimated: 27

  • SIREN

    821713344
  • Engaged corporates

    4
    1 2
  • Added in Motherbase

    6 years, 4 months ago
Description
  • Value proposition

    Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. Vivet Therapeutics is focused on optimizing gene therapy through collaborating with the Fundacion para la Investigacion Medica Aplicada (CIMA, Universidad de Navarra) to develop new AAV vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression.

    Gene Therapy

  • Original language

    Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. Vivet Therapeutics is focused on optimizing gene therapy through collaborating with the Fundacion para la Investigacion Medica Aplicada (CIMA, Universidad de Navarra) to develop new AAV vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression.

Corporate interactions BETA
Corporate TypeTweets Articles
 EU Green Capital
EU Green Capital
European Union, Environmental Services
EU Green Capital
European Union, Environmental Services
Other

6 Sep 2024


Bpifrance
Bpifrance
Bank, Banking
Bpifrance
Bank, Banking
Other

1 Feb 2024


Servier Pharmaceuticals
Servier Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Servier Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Other

1 Dec 2021


Eurazeo
Eurazeo
Finance, Financial Services
Eurazeo
Finance, Financial Services
Not capitalistic
Partnership
Not event

20 Mar 2019


Similar entities
Loading...
Loading...
Social network dynamics